Aids vaccines: Back to 'plan A'

被引：15

作者：

Check, E

机构：

来源：

NATURE | 2003年 / 423卷 / 6943期

关键词：

D O I：

10.1038/423912a

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Vaccines

引用

收藏

页码：912 / 914

页数：3

相关论文

共 10 条

[1] PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160 [J].

BERMAN, PW ;

GREGORY, TJ ;

RIDDLE, L ;

NAKAMURA, GR ;

CHAMPE, MA ;

PORTER, JP ;

WURM, FM ;

HERSHBERG, RD ;

COBB, EK ;

EICHBERG, JW .

NATURE, 1990, 345 (6276) :622-625

[2] EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY [J].

BURTON, DR ;

PYATI, J ;

KODURI, R ;

SHARP, SJ ;

THORNTON, GB ;

PARREN, PWHI ;

SAWYER, LSW ;

HENDRY, RM ;

DUNLOP, N ;

NARA, PL ;

LAMACCHIA, M ;

GARRATTY, E ;

STIEHM, ER ;

BRYSON, YJ ;

CAO, YZ ;

MOORE, JP ;

HO, DD ;

BARBAS, CF .

SCIENCE, 1994, 266 (5187) :1024-1027

[3] Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization [J].

Chakrabarti, BK ;

Kong, W ;

Wu, B ;

Yang, ZY ;

Friborg, J ;

Ling, X ;

King, SR ;

Montefiori, DC ;

Nabel, GJ .

JOURNAL OF VIROLOGY, 2002, 76 (11) :5357-5368

[4] NEUTRALIZATION OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES BY THE BROADLY REACTIVE ANTI-V3 MONOCLONAL-ANTIBODY, 447-52D [J].

CONLEY, AJ ;

GORNY, MK ;

KESSLER, JA ;

BOOTS, LJ ;

OSSORIOCASTRO, M ;

KOENIG, S ;

LINEBERGER, DW ;

EMINI, EA ;

WILLIAMS, C ;

ZOLLAPAZNER, S .

JOURNAL OF VIROLOGY, 1994, 68 (11) :6994-7000

[5] Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression [J].

Huang, Y ;

Kong, WP ;

Nabel, GJ .

JOURNAL OF VIROLOGY, 2001, 75 (10) :4947-4951

[6] Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1 [J].

Mascola, JR ;

Snyder, SW ;

Weislow, OS ;

Belay, SM ;

Belshe, RB ;

Schwartz, DH ;

Clements, ML ;

Dolin, R ;

Graham, BS ;

Gorse, GJ ;

Keefer, MC ;

McElrath, MJ ;

Walker, MC ;

Wagner, KF ;

McNeil, JG ;

McCutchan, FE ;

Burke, DS .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02) :340-348

[7] Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design [J].

Pantophlet, R ;

Wilson, IA ;

Burton, DR .

JOURNAL OF VIROLOGY, 2003, 77 (10) :5889-5901

[8] Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design [J].

Saphire, EO ;

Parren, PWHI ;

Pantophlet, R ;

Zwick, MB ;

Morris, GM ;

Rudd, PM ;

Dwek, RA ;

Stanfield, RL ;

Burton, DR ;

Wilson, IA .

SCIENCE, 2001, 293 (5532) :1155-1159

[9] Alternative conformations of HIV-1V3 loops mimic β hairpins in chemokines, suggesting a mechanism for coreceptor selectivity [J].

Sharon, M ;

Kessler, N ;

Levy, R ;

Zolla-Pazner, S ;

Görlach, M ;

Anglister, J .

STRUCTURE, 2003, 11 (02) :225-236

[10] Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 [J].

Trkola, A ;

Purtscher, M ;

Muster, T ;

Ballaun, C ;

Buchacher, A ;

Sullivan, N ;

Srinivasan, K ;

Sodroski, J ;

Moore, JP ;

Katinger, H .

JOURNAL OF VIROLOGY, 1996, 70 (02) :1100-1108